Ostrum Asset Management acquired a new position in Markel Co. (NYSE:MKL) during the first quarter, according to the company in its most recent filing with the SEC. The fund acquired 138 shares of the insurance provider’s stock, valued at approximately $161,000.

A number of other hedge funds have also recently modified their holdings of MKL. The Manufacturers Life Insurance Company increased its position in shares of Markel by 10.7% in the 1st quarter. The Manufacturers Life Insurance Company now owns 590 shares of the insurance provider’s stock worth $691,000 after purchasing an additional 57 shares during the last quarter. Blair William & Co. IL grew its position in shares of Markel by 117.8% during the 1st quarter. Blair William & Co. IL now owns 758 shares of the insurance provider’s stock valued at $887,000 after buying an additional 410 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in shares of Markel by 3.8% during the 1st quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 5,221 shares of the insurance provider’s stock valued at $6,110,000 after buying an additional 192 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its position in shares of Markel by 5.1% during the 1st quarter. Nomura Asset Management Co. Ltd. now owns 2,151 shares of the insurance provider’s stock valued at $2,517,000 after buying an additional 104 shares during the last quarter. Finally, Signition LP grew its position in shares of Markel by 25.7% during the 1st quarter. Signition LP now owns 264 shares of the insurance provider’s stock valued at $309,000 after buying an additional 54 shares during the last quarter. Hedge funds and other institutional investors own 76.23% of the company’s stock.

A number of equities research analysts recently weighed in on MKL shares. ValuEngine downgraded shares of Markel from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. William Blair raised shares of Markel from a “market perform” rating to an “outperform” rating in a research report on Monday, March 19th. Zacks Investment Research raised shares of Markel from a “hold” rating to a “buy” rating and set a $1,287.00 price objective for the company in a research report on Wednesday, April 11th. Argus started coverage on shares of Markel in a research report on Wednesday, April 11th. They set a “hold” rating for the company. Finally, Boenning Scattergood set a $1,250.00 price objective on shares of Markel and gave the company a “buy” rating in a research report on Friday, April 27th. Four research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $1,237.50.

In other news, insider Nora N. Crouch sold 90 shares of the company’s stock in a transaction that occurred on Tuesday, May 22nd. The shares were sold at an average price of $1,151.58, for a total value of $103,642.20. Following the completion of the sale, the insider now directly owns 2,577 shares of the company’s stock, valued at approximately $2,967,621.66. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Vice Chairman Steven A. Markel sold 200 shares of the company’s stock in a transaction that occurred on Thursday, March 29th. The stock was sold at an average price of $1,165.33, for a total transaction of $233,066.00. Following the completion of the sale, the insider now directly owns 105,629 shares of the company’s stock, valued at $123,092,642.57. The disclosure for this sale can be found here. Insiders have sold a total of 1,390 shares of company stock valued at $1,590,244 over the last three months. 2.46% of the stock is currently owned by company insiders.

Markel stock traded down $14.30 during midday trading on Monday, reaching $1,098.70. 173 shares of the stock traded hands, compared to its average volume of 29,593. The company has a quick ratio of 0.59, a current ratio of 0.59 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $15.46 billion, a price-to-earnings ratio of 302.76 and a beta of 0.89. Markel Co. has a fifty-two week low of $949.72 and a fifty-two week high of $1,194.98.

Markel (NYSE:MKL) last posted its earnings results on Tuesday, April 24th. The insurance provider reported $11.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.71 by $2.68. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.61 billion. Markel had a net margin of 4.19% and a return on equity of 1.47%. research analysts expect that Markel Co. will post 38.48 earnings per share for the current year.

Markel Company Profile

Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, the United Kingdom, Canada, and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment offers general and professional liability, property, personal line, program, and workers' compensation insurance products, as well as other insurance product lines, such as ocean marine, surety, CPI, and coverages.

Want to see what other hedge funds are holding MKL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Markel Co. (NYSE:MKL).

Institutional Ownership by Quarter for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.